Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
TB-500
Recovery Speed3x
Studies8
Participants1,205
StatusAvailable

TB-500

Thymosin Beta-4

TB-500 is a synthetic version of thymosin beta-4, a naturally occurring protein that plays a crucial role in wound healing and tissue repair. It promotes cellular migration, angiogenesis, and tissue regeneration through actin-binding activity and growth factor upregulation. Extensively studied for cardiac protection, wound healing, and muscle injury recovery.

Clinical Benefits

Accelerated wound healing and tissue repair
Enhanced cellular migration to injury sites
Promotes angiogenesis (new blood vessel formation)
Reduces scar tissue formation
Improves tissue elasticity and function
Cardiac protection and recovery

Mechanism of Action

TB-500 functions as an actin-binding protein that regulates cellular migration and tissue repair processes. It promotes the upregulation of key growth factors including VEGF (vascular endothelial growth factor), IGF-1 (insulin-like growth factor), and FGF (fibroblast growth factor). TB-500 enhances angiogenesis through VEGF-mediated pathways, accelerates collagen synthesis, and modulates inflammatory responses to optimize healing outcomes.

Key Action:

Proven Results

78%
Maximum Weight Loss
Clinical research data
65%
Diabetes Risk Reduction
Clinical research data
1,205
Total Participants
Research studies
42%
CV Risk Reduction
Clinical data

Medical Disclaimer

TB-500 is a research chemical not approved by the FDA for human therapeutic use. This information is for educational and research purposes only and should not replace consultation with healthcare providers. Individual results may vary significantly. Professional medical supervision is recommended for all applications.